Immuno-oncology - Свежие новости | |
Sanofi Acquiring Synthorx for $2.5B to Strengthen Immuno-Oncology Portfolio
Coinspeaker Sanofi Acquiring Synthorx for $2. 5B to Strengthen Immuno-Oncology PortfolioSanofi announced that it had agreed to buy California-headquartered biotechnology firm Synthorx in a cash deal worth about $2. дальше »
2019-12-9 13:32 | |
|